Meeting
2019 ASCO Annual Meeting
Cardiovascular complications of immune checkpoint inhibitor therapy.
Authors
Samip R. Master
Louisiana State University Health Sciences Center, Shreveport, LA
Samip R. Master , Arelis Robinson , Glenn Morris Mills , Richard P Mansour
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Immunotherapy and Tumor Immunobiology
Track
Developmental Therapeutics—Immunotherapy
Sub Track
Immune Checkpoint Inhibitors
Citation
J Clin Oncol 37, 2019 (suppl; abstr 2568)
DOI
10.1200/JCO.2019.37.15_suppl.2568
Abstract #
2568
Poster Bd #
212
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Early combination with mycophenolate mofetil for immune-related hepatitis in patients with solid tumors treated with immune checkpoint inhibitors.
First Author: Yukiko Shimoda Igawa
Poster
2018 ASCO Quality Care Symposium
A data driven approach to immunotherapy toxicity management.
First Author: Sadiqa Mahmood
Poster
2023 ASCO Annual Meeting
Safety of checkpoint inhibitors in older patients with genitourinary cancers.
First Author: Brian Hemendra Ramnaraign
Poster
2022 ASCO Annual Meeting
Pan-cancer (ca) analysis of the safety and efficacy of immune checkpoint inhibitors (ICI) in patients (pts) living with HIV (PLWH): Results from the international CATCH-IT consortium.
First Author: Talal El Zarif